US Steering Committee

Brian M. Alexander, MD, MPH

Board member, Global Coalition for Adaptive Research
SVP, Roche/Genentech Pharma R&D
Associate Professor, Radiation Oncology, Harvard Medical School
Disease Center Leader, Radiation Oncology, Center for Neuro-Oncology, Dana-Farber Cancer Institute
Director, Therapeutic Science, Harvard Medical School


Derek C. Angus , MD, MPH, FRCP

Chair of the Department of Critical Care Medicine, UPMC and University of Pittsburgh School of Medicine
Associate Vice Chancellor for Health Care Innovation, Health Sciences
Distinguished Professor, Mitchell P. Fink Professor, and Chair of Critical Care Medicine,
Professor of Medicine, School of Medicine
Professor of Health Policy and Management, Graduate School of Public Health
Professor of Clinical and Translational Science, University of Pittsburgh
Executive Vice President, UPMC, and Chief Innovation Officer


Scott Berry, MS, PhD

President & Senior Statistical Scientist,
Berry Consultants


Meredith Buxton, PhD, MPH

Chief Executive Officer & President,
Global Coalition for Adaptive Research 


David Huang, MD, MPH

Professor of Critical Care Medicine and Emergency Medicine
Research Director, University of Pittsburgh School of Medicine


Florian B. Mayr, MD, MPH

Assistant Professor of Critical Care Medicine,
University of Pittsburgh School of Medicine


Bryan J. McVerry, MD

Pulmonary, Allergy and Critical Care Medicine
Associate Professor of Medicine,
Environmental and Occupational Health,
Clinical and Translational Science
Associate Chief, Strategy and Development
University of Pittsburgh School of Medicine


Robert F. Murray, III

Chief Business Officer,
Global Coalition for Adaptive Research

Tracey Roberts, BSN

Associate Director, Clinical Operations,
Global Coalition for Adaptive Research


Christopher W. Seymour, MD, MSC

Associate Professor of Critical Care Medicine and Emergency Medicine,
University of Pittsburgh School of Medicine

REMAP-CAP / COVID

Evaluating Multiple Treatments Worldwide —

Critically Needed Now.

20 x

SARS-CoV-2 (the COVID-19-causing virus) binds 10-20x more tightly to human cells than SARS-CoV (the virus responsible for SARS)

65 +

The greatest percentage of those who die from COVID-19 are age 65+ and living with a chronic disease

80 %

About 80% of COVID-19 infections are mild or asymptomatic, 15% result in moderate to severe symptoms and 5% are critical